End-to-side Versus Side-to-side Anastomosis With Distal Vein Ligation for Arteriovenous Fistula Creation

January 9, 2020 updated by: Mansoura University

End-to-side Versus Side-to-side Anastomosis With Distal Vein Ligation for Arteriovenous Fistula Creation: a Randomized Controlled Study

End-stage renal disease (ESRD) arises from many heterogeneous disease pathways that alter the function and structure of the kidney irreversibly, over months or years.End-stage renal disease (ESRD) arises from many heterogeneous disease pathways that alter the function and structure of the kidney irreversibly, over months or years. Haemodialysis (HD) is a lifeline therapy for patients with ESRD. Our study to compare methods of AVF creation, side to side and end to side . This randomized controlled trial .

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

End-to-side versus side-to-side anastomosis with distal vein ligation for arteriovenous fistula creation: A prospective randomized controlled study

Introduction: Arteriovenous fistula (AVF) is the lifeline for patients with chronic renal failure on hemodialysis. The international guidelines recommend patient's referral for access replacement 6 months prior to predicted hemodialysis. The sites being preferred for access replacement are distal arm AVF, proximal arm AVF, basilic vein transposition or graft insertion, respectively (1) Meticulous preoperative assessment and patient selection play great role in achieving functioning AVF with long term patency. AVF maintenance always requires multi-disciplinary approach, with surgeons, nephrologist, dialysis nurses and the patients themselves working hand in hand. Any break in this circle will lead to failure of the AVF, and consequently, failure of hemodialysis. Surgical technique is of paramount importance for long term patency of AVF. There is an ongoing debate about the best technique to do the anastomosis between the artery and the vein; end to side, or side to side. This issue was addressed by very few randomized controlled studies (2,3,4).

Aim of the study: To compare the results of both surgical techniques for creation of arteriovenous anastomosis; End vein to side artery (ETS) versus Side vein to side artery (STS).

Patients and Methods

  • Study location: Study protocol will be submitted for approval by Mansoura medical research ethics committee, faculty of medicine, Mansoura University.
  • Study design: This is Prospective Randomized controlled trials that is going to be conducted at in department of vascular surgery Mansoura University Hospitals
  • Time of study: The study will be conducted during the year 2017-2019.
  • Study population: Study population will be on Patients referred to Vascular surgery department for creation of Hemodialysis access. Patients will be advised to undergo elective surgery for AVF once their renal Glomerular Filtration Rate Estimated (eGFR) is less than 15 ml/min.
  • Inclusion criteria: All renal failure patients requiring creation of arm AVF, including distal Radio-cephalic, Ulno-basilic, proximal brachio-cephalic or brachio-basilic configurations
  • Exclusion criteria: Revision AVF, Synthetic graft AVF or lower limb AVF, Patients with absent distal pulses and chronic ischemia of the upper limb and Recent cannulation of puncture of the vein within 2 weeks before its use in AVF creation.
  • Primary End Point: Primary patency of Arterio-venous Fistula and Functional Maturation, ready fistula for cannulation, vein length at least 10 cm, diameter more than 6 mm, depth not more than 6 mm and ability of the access to deliver a flow rate 350 to 400ml/min and maintain dialysis for 4 hours.
  • Secondary End Points: Secondary patency, Complication rate failure of maturation, bleeding, infection, steel syndrome and aneurysmal dilatation at anastomosis site
  • Target number for recruitment: 50 patients in each group.
  • Pre-operative assessment: All patients will undergo clinical assessment as well as routine duplex scan for marking of artery and a patent vein suitable for creation of AVF, with a minimum vein diameter of 2.5 mm for distal fistula and 3 mm for proximal ones.
  • Method of Randomization: Computer based randomization.
  • Surgical technique: Patients can have the procedure under general, local anesthetic or regional block according to suitability and patients' preference. Mobilization of the suitable artery and vein, creation of fistula using 6/0 prolene for anastomosis in continuous sutures, either ETS or STS with ligation of the distal end of the vein. Arteriotomy size will range from 7 to 10 mm for proximal AVF and from 12 to 15 mm for distal AVF, according to the size of the artery.
  • Sites sharing in the study: Mansoura University Hospital
  • Post-operative follow-up: Review in clinic on day 6, week 6, months 3 & 6, Duplex scan for assessment of flow in 6 weeks, 3 and 6 months.

Statistical analysis: The data was analyzed using Statistical Package for the Social Sciences. The Significant difference between the flow rate volume in both groups (continuous variable) will be verified by a two-sample test between the two groups. The data analyzed using Cochrane and ANOVA test. Categorical demographic variables were expressed as a proportion of the population and compared with a two-tailed Fisher's exact test.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Mansoura University
      • Mansoura, Mansoura University, Egypt, 35111
        • Mansoura

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

• Study population will be on Patients referred to Vascular surgery department for creation of Hemodialysis access. Patients will advised to undergo elective surgery for AVF once their renal Glomerular Filtration Rate Estimated (eGFR) is less than 15 ml/min.

Description

Inclusion Criteria:

  • All renal failure patients requiring creation of arm AVF
  • Including distal Radio-cephalic, Ulno-basilic, proximal brachio-cephalic or brachio-basilic configurations

Exclusion Criteria:

  • Revision AVF, Synthetic graft AVF or lower limb AVF.
  • Patients with absent distal pulses and chronic ischemia of the upper limb.
  • Recent cannulation of puncture of the vein within 2 weeks before its use in AVF creation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
End To Side
End to Side Anastomosis
Type of arteriovenous anastomosis
Side To Side
Side To Side Anastomosis
Type of arteriovenous anastomosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Maturation of Arterio-venous Fistula
Time Frame: Six Months
Ready fistula for cannulation , vein length at least 10 cm , diameter more than 6 mm ,depth not more than 6 mm and ability of the access to deliver a flow rate 350 to 400ml/min and maintain dialysis for 4 hours.
Six Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complication rate and failure of maturation
Time Frame: Six Months
Bleeding, infection, steel syndrome and aneurysmal dilatation at anastomosis site
Six Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2018

Primary Completion (Actual)

September 4, 2018

Study Completion (Actual)

February 4, 2019

Study Registration Dates

First Submitted

January 7, 2020

First Submitted That Met QC Criteria

January 7, 2020

First Posted (Actual)

January 10, 2020

Study Record Updates

Last Update Posted (Actual)

January 13, 2020

Last Update Submitted That Met QC Criteria

January 9, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arterio-venous Fistula

Clinical Trials on AVF anastomosis

3
Subscribe